Latest stories on OPTH
Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity
GlobeNewswire56 · neutralproduct/pr
Psychedelic: Optimi completes MDMA production for three programs
The Fly58 · neutralproduct/pr
Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia
Business Insider64 · neutralproduct/pr
Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia
GlobeNewswire63 · neutralproduct/pr
Optimi Health to Present at the ThinkEquity Conference
GlobeNewswire55 · neutralgeneral
Optimi Health Appoints Melanie Pump to Board of Directors
GlobeNewswire55 · neutralgeneral
Psychedelic: Optimi completes psilocybin production for Phase 2 trial
The Fly59 · neutralproduct/pr
Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply
GlobeNewswire63 · neutralproduct/pr
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
Business Insider55 · neutralgeneral
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
GlobeNewswire56 · neutralgeneral
Elon Musk Once Said Psychedelics Could Help PTSD — Now FDA Holds Hearing as Optimi Health Advances MDMA Trial
Yahoo Top63 · neutralproduct/pr
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
Business Insider67 · bullishproduct/pr
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
GlobeNewswire67 · bullishproduct/pr
Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy
The Fly56 · neutralproduct/pr
Optimi Health to initiate Phase 2 trial of psilocybin-assisted therapy for MDD
The Fly63 · neutralproduct/pr
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
Business Insider63 · neutralproduct/pr
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
GlobeNewswire63 · neutralproduct/pr
Optimi Health to Present at H.C. Wainwright Global Investment Conference
TipRanks56 · neutralgeneral
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
Business Insider56 · neutralgeneral
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
GlobeNewswire56 · neutralgeneral
OPTH Competitors for Optimi Health Corp Stock
Barchart50 · neutralgeneral
OPTH Competitors for Optimi Health Corp Stock
Barchart50 · neutralgeneral
Optimi Health Corp. GAAP EPS of -$0.56, revenue of $239.7M
Seeking Alpha34 · bearishearnings
Optimi Health files to sell 21.94M common shares for holders
The Fly24 · bearishgeneral
Optimi Health Establishes Discretionary Equity Facility
Business Insider28 · bearishgeneral